MNTA Financial Facts
Product revenue: 23.34MTotal operating expenses: 47.33M
See Full Income Statement
Accumulated other comprehensive income (loss): 250K
Other long term liabilities: 1.86M
See Full Balance Sheet
Momenta Pharmaceuticals Inc (MNTA) Earnings
|
Expand Research on MNTA
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -8.9% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.3% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/10/20 |  |
Q220 | -$0.48 | -$0.39 | -$0.09 | $6.61M | $5.56M | N/A |  | | Details |
| 5/7/20 | |
Q120 | -$0.34 | -$0.48 | +$0.14 | $8.89M | $4.33M | N/A | | | Details |
| 2/26/20 | |
Q419 | -$0.85 | -$0.56 | -$0.29 | $8.18M | $5.56M | N/A | | | Details |
| 10/31/19 | |
Q319 | -$0.45 | -$0.50 | +$0.05 | $5.55M | $5.24M | N/A | | | Details |
| 8/2/19 | |
Q219 | -$1.19 | -$0.42 | -$0.77 | $5.18M | $9.2M | N/A | | | Details |
| 5/2/19 | |
Q119 | -$0.46 | -$0.43 | -$0.03 | $4.11M | $10.12M | N/A | | | Details |
| 2/22/19 | |
Q418 | -$0.10 | -$0.51 | +$0.41 | $42.8M | $17.11M | N/A | | | Details |
| 11/7/18 | |
Q318 | -$0.65 | -$0.57 | -$0.08 | $14.88M | $16.99M | N/A | | | Details |
